Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 4Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 17Leukemia, Promyelocytic, Acute 10Leukemia 9Myelodysplastic Syndromes 8Melanoma 5Congenital Abnormalities 4Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Multiple Myeloma 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Uterine Cervical Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroblastoma 2Lymphoma, T-Cell, Cutaneous 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Wilms Tumor 1Uterine Cervical Dysplasia 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Kidney Neoplasms 1

Interventions

Dexamethasone 363Bortezomib 232Lenalidomide 202Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 55Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Tretinoin × Clear all
NCT02751255 2023-04-28

DARA/ATRA

Amsterdam UMC, location VUmc

Phase 1/2 Completed
60 enrolled
Plasma cell

Multiple Myeloma

NCT02401295 2017-02-23

ATRA, Celecoxib, and Itraconazole as Maintenance

University of Iowa

Phase 1 Completed
1 enrolled
Plasma cell

Multiple Myeloma

NCT00400556 2006-11-17

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Peter MacCallum Cancer Centre, Australia

Phase 1 Completed
6 enrolled
DermatologicLymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡